FDA Approved Medical Products for:

Pediatric Crohns disease

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Infliximab
Trade Name
(Manufacturer Name)
Remicade®
(Centocor Ortho Biotech Inc.)
Indication
The FDA has approved this product to be used in this manner.
For reducing signs and symptoms and inducing and maintaining clinical remission in pediatric patients with moderately to severely active Crohn's disease who have had an inadequate response to conventional therapy
More Information about this product Drug Information Portal